\BOOKMARK [0][-]{chapter*.6}{Preamble\040about\040Interdisciplinary\040Research}{}% 1
\BOOKMARK [1][-]{section*.7}{What\040does\040interdisciplinarity\040in\040science\040mean\040in\040XXI\040century?}{chapter*.6}% 2
\BOOKMARK [1][-]{section*.10}{Strengths,\040Weaknesses\040Opportunities,\040Threats\040\(SWOT\)\040of\040an\040interdisciplinary\040PhD\040-\040personal\040perspective}{chapter*.6}% 3
\BOOKMARK [1][-]{section*.12}{The\040origins\040of\040the\040PhD\040topic}{chapter*.6}% 4
\BOOKMARK [0][-]{chapter*.13}{Organisation\040of\040the\040dissertation}{}% 5
\BOOKMARK [-1][-]{part.1}{I\040Introduction}{}% 6
\BOOKMARK [0][-]{chapter.1}{Immuno-biology\040of\040cancer}{part.1}% 7
\BOOKMARK [1][-]{section.1.1}{Cancer\040disease}{chapter.1}% 8
\BOOKMARK [2][-]{subsection.1.1.1}{Historical\040understanding\040of\040cancer}{section.1.1}% 9
\BOOKMARK [2][-]{subsection.1.1.2}{Tumor\040Microenvironment\040as\040a\040complex\040system}{section.1.1}% 10
\BOOKMARK [3][-]{subsubsection.1.1.2.1}{Interactions\040between\040TME\040and\040Tumor}{subsection.1.1.2}% 11
\BOOKMARK [3][-]{subsubsection.1.1.2.2}{Two-faced\040nature\040of\040immune\040cells:\040context-dependent\040functional\040plasticity}{subsection.1.1.2}% 12
\BOOKMARK [3][-]{subsubsection.1.1.2.3}{Immune\040cell\040\(sub\)types\040in\040TME}{subsection.1.1.2}% 13
\BOOKMARK [3][-]{subsubsection.1.1.2.4}{Summary}{subsection.1.1.2}% 14
\BOOKMARK [1][-]{section.1.2}{Quantifying\040and\040qualifying\040immune\040infiltration\040\(data\)}{chapter.1}% 15
\BOOKMARK [2][-]{subsection.1.2.1}{Cell\040sorting}{section.1.2}% 16
\BOOKMARK [3][-]{subsubsection.1.2.1.1}{Flow\040cytometry}{subsection.1.2.1}% 17
\BOOKMARK [3][-]{subsubsection.1.2.1.2}{Mass\040cytometry}{subsection.1.2.1}% 18
\BOOKMARK [2][-]{subsection.1.2.2}{Microscope\040Staining}{section.1.2}% 19
\BOOKMARK [3][-]{subsubsection.1.2.2.1}{Tissue\040Microarrays}{subsection.1.2.2}% 20
\BOOKMARK [2][-]{subsection.1.2.3}{omics}{section.1.2}% 21
\BOOKMARK [3][-]{subsubsection.1.2.3.1}{Transcriptome}{subsection.1.2.3}% 22
\BOOKMARK [3][-]{subsubsection.1.2.3.2}{Single\040cell\040RNA-seq}{subsection.1.2.3}% 23
\BOOKMARK [3][-]{subsubsection.1.2.3.3}{Epigenome}{subsection.1.2.3}% 24
\BOOKMARK [3][-]{subsubsection.1.2.3.4}{Copy\040number\040variation\040\(CNV\)\040and\040Copy\040number\040aberration\040\(CNA\)}{subsection.1.2.3}% 25
\BOOKMARK [3][-]{subsubsection.1.2.3.5}{Spatial\040transcriptomics}{subsection.1.2.3}% 26
\BOOKMARK [1][-]{section.1.3}{From\040cancer\040phenotyping\040to\040immune\040therapies}{chapter.1}% 27
\BOOKMARK [2][-]{subsection.1.3.1}{Cancer\040immune\040phenotypes}{section.1.3}% 28
\BOOKMARK [2][-]{subsection.1.3.2}{Scoring\040the\040immune\040infiltration}{section.1.3}% 29
\BOOKMARK [3][-]{subsubsection.1.3.2.1}{Immunoscore}{subsection.1.3.2}% 30
\BOOKMARK [3][-]{subsubsection.1.3.2.2}{Spatiotemporal\040dynamics\040of\040Intratumoral\040Immune\040Cells\040of\040Colorectal\040Cancer}{subsection.1.3.2}% 31
\BOOKMARK [3][-]{subsubsection.1.3.2.3}{Immunophenoscore}{subsection.1.3.2}% 32
\BOOKMARK [3][-]{subsubsection.1.3.2.4}{The\040immune\040landscape\040of\040cancer}{subsection.1.3.2}% 33
\BOOKMARK [3][-]{subsubsection.1.3.2.5}{A\040pan-cancer\040landscape\040of\040immune-cancer\040interactions\040in\040solid\040tumors}{subsection.1.3.2}% 34
\BOOKMARK [3][-]{subsubsection.1.3.2.6}{Immune\040maps}{subsection.1.3.2}% 35
\BOOKMARK [3][-]{subsubsection.1.3.2.7}{Summary}{subsection.1.3.2}% 36
\BOOKMARK [2][-]{subsection.1.3.3}{Immune\040signatures\040-\040biological\040perspective}{section.1.3}% 37
\BOOKMARK [2][-]{subsection.1.3.4}{Cancer\040therapies}{section.1.3}% 38
\BOOKMARK [2][-]{subsection.1.3.5}{Recent\040progress\040in\040immuno-therapies}{section.1.3}% 39
\BOOKMARK [1][-]{section.1.4}{Summary\040of\040the\040chapter}{chapter.1}% 40
\BOOKMARK [0][-]{chapter.2}{Mathematical\040foundation\040of\040cell-type\040deconvolution\040of\040biological\040data}{part.1}% 41
\BOOKMARK [1][-]{section.2.1}{Introduction\040to\040supervised\040and\040unsupervised\040learning}{chapter.2}% 42
\BOOKMARK [2][-]{subsection.2.1.1}{Supervised\040learning}{section.2.1}% 43
\BOOKMARK [2][-]{subsection.2.1.2}{Unsupervised\040learning}{section.2.1}% 44
\BOOKMARK [2][-]{subsection.2.1.3}{Low-dimensional\040embedding\040for\040visualization}{section.2.1}% 45
\BOOKMARK [1][-]{section.2.2}{Impact\040of\040machine\040learning\040on\040Healthcare}{chapter.2}% 46
\BOOKMARK [1][-]{section.2.3}{Types\040of\040deconvolution}{chapter.2}% 47
\BOOKMARK [1][-]{section.2.4}{Cell-type\040deconvolution\040of\040bulk\040transcriptomes}{chapter.2}% 48
\BOOKMARK [2][-]{subsection.2.4.1}{Literature\040overview}{section.2.4}% 49
\BOOKMARK [2][-]{subsection.2.4.2}{Regression-based\040methods}{section.2.4}% 50
\BOOKMARK [2][-]{subsection.2.4.3}{Enrichment-based\040methods}{section.2.4}% 51
\BOOKMARK [2][-]{subsection.2.4.4}{Probabilistic\040methods}{section.2.4}% 52
\BOOKMARK [2][-]{subsection.2.4.5}{Convex-hull\040based\040methods}{section.2.4}% 53
\BOOKMARK [2][-]{subsection.2.4.6}{Matrix\040factorisation\040methods}{section.2.4}% 54
\BOOKMARK [3][-]{subsubsection.2.4.6.1}{Principal\040Components\040Analysis}{subsection.2.4.6}% 55
\BOOKMARK [3][-]{subsubsection.2.4.6.2}{Non-negative\040matrix\040factorisation}{subsection.2.4.6}% 56
\BOOKMARK [3][-]{subsubsection.2.4.6.3}{Independent\040Components\040Analysis}{subsection.2.4.6}% 57
\BOOKMARK [2][-]{subsection.2.4.7}{Attractor\040metagenes}{section.2.4}% 58
\BOOKMARK [2][-]{subsection.2.4.8}{Others\040aspects}{section.2.4}% 59
\BOOKMARK [3][-]{subsubsection.2.4.8.1}{Types\040of\040biological\040reference}{subsection.2.4.8}% 60
\BOOKMARK [3][-]{subsubsection.2.4.8.2}{Data\040normalization}{subsection.2.4.8}% 61
\BOOKMARK [3][-]{subsubsection.2.4.8.3}{Validation}{subsection.2.4.8}% 62
\BOOKMARK [3][-]{subsubsection.2.4.8.4}{Statistical\040significance}{subsection.2.4.8}% 63
\BOOKMARK [2][-]{subsection.2.4.9}{Summary}{section.2.4}% 64
\BOOKMARK [1][-]{section.2.5}{Deconvolution\040of\040other\040data\040types}{chapter.2}% 65
\BOOKMARK [2][-]{subsection.2.5.1}{DNA\040methylation\040data}{section.2.5}% 66
\BOOKMARK [2][-]{subsection.2.5.2}{Copy\040number\040aberrations\040\(CNA\)}{section.2.5}% 67
\BOOKMARK [1][-]{section.2.6}{Summary\040of\040the\040chapter}{chapter.2}% 68
\BOOKMARK [0][-]{chapter*.33}{Objectives}{part.1}% 69
\BOOKMARK [-1][-]{part.2}{II\040Results}{}% 70
\BOOKMARK [0][-]{chapter.3}{Study\040of\040sensitivity\040and\040reproducibility\040of\040known\040methods}{part.2}% 71
\BOOKMARK [1][-]{section.3.1}{Finding\040optimal\040number\040of\040components\040and\040over-decomposition\040of\040transcriptopmes}{chapter.3}% 72
\BOOKMARK [1][-]{section.3.2}{}{chapter.3}% 73
\BOOKMARK [1][-]{section.3.3}{REPRODUCIBILITY\040OF\040NMF\040VERSUS\040ICA\040\(VS\040CAM?\)}{chapter.3}% 74
\BOOKMARK [2][-]{subsection.3.3.1}{Comparing\040metagenes\040obtained\040with\040NMF\040vs\040ICA.}{section.3.3}% 75
\BOOKMARK [1][-]{section.3.4}{Impact\040of\040modification\040of\040signatures\040list\040on\040result\040for\040signature-based\040deconvolution\040methods}{chapter.3}% 76
\BOOKMARK [0][-]{chapter.4}{Deconvolution\040of\040transcriptomes\040and\040methylomes}{part.2}% 77
\BOOKMARK [1][-]{section.4.1}{From\040blind\040deconvolution\040to\040cell-type\040quantification:\040general\040overview}{chapter.4}% 78
\BOOKMARK [2][-]{subsection.4.1.1}{The\040ICA-based\040deconvolution\040of\040Transcriptomes}{section.4.1}% 79
\BOOKMARK [2][-]{subsection.4.1.2}{Interpretation\040of\040Independent\040components}{section.4.1}% 80
\BOOKMARK [3][-]{subsubsection.4.1.2.1}{Correlation\040based\040identification\040of\040confounding\040factors}{subsection.4.1.2}% 81
\BOOKMARK [3][-]{subsubsection.4.1.2.2}{Identification\040of\040immune\040cell\040types\040with\040enrichment\040test\040/\040other}{subsection.4.1.2}% 82
\BOOKMARK [2][-]{subsection.4.1.3}{Transforming\040metagenes\040into\040signature\040matrix}{section.4.1}% 83
\BOOKMARK [2][-]{subsection.4.1.4}{Regression-based\040estimation\040of\040cell-type\040proportions\040:\040solving\040system\040of\040equations}{section.4.1}% 84
\BOOKMARK [1][-]{section.4.2}{DeconICA\040R\040package\040for\040ICA-based\040deconvolution}{chapter.4}% 85
\BOOKMARK [2][-]{subsection.4.2.1}{Demo}{section.4.2}% 86
\BOOKMARK [0][-]{chapter.5}{Comparative\040analysis\040of\040cancer\040immune\040infiltration}{part.2}% 87
\BOOKMARK [0][-]{chapter.6}{Heterogeneity\040of\040immune\040cell\040types}{part.2}% 88
\BOOKMARK [-1][-]{part.3}{III\040Discussion}{}% 89
\BOOKMARK [0][-]{chapter.7}{Discussion}{part.3}% 90
\BOOKMARK [0][-]{chapter.8}{Conclusions\040and\040perspectives}{part.3}% 91
\BOOKMARK [0][-]{chapter*.36}{Annexes}{part.3}% 92
\BOOKMARK [1][-]{section*.37}{Dc\040subtypes}{chapter*.36}% 93
\BOOKMARK [1][-]{section*.38}{DreamIdea\040Challenge}{chapter*.36}% 94
\BOOKMARK [1][-]{section*.39}{Full\040list\040of\040publications}{chapter*.36}% 95
\BOOKMARK [1][-]{section*.40}{CV}{chapter*.36}% 96
\BOOKMARK [0][-]{chapter*.41}{Post\040Scriptum:\040Thesis\040writing}{part.3}% 97
\BOOKMARK [0][-]{chapter*.41}{Bibliography}{part.3}% 98
